Literature DB >> 17344105

Chromatographic and mass spectrometric methods for quantitative determination of 3-nitrotyrosine in biological samples and their application to human samples.

Henrik Ryberg1, Kenneth Caidahl.   

Abstract

The permanent modification of soluble and protein-associated tyrosine by nitration results in the formation of 3-nitrotyrosine, which can be used as a marker of "nitro-oxidative" damage to proteins. Based on the analysis of patient materials, over 40 different diseases and/or conditions have been linked to increased nitration of tyrosine. They include many cardiovascular diseases, conditions associated with immunological reactions and neurological diseases. In this article we review the existing chromatographic and mass spectrometric methods for quantitative measurements of 3-nitrotyrosine in different human biological samples including plasma, either from the free amino acid pool or from hydrolyzed proteins from different matrices.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344105     DOI: 10.1016/j.jchromb.2007.02.001

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  10 in total

1.  Relative quantitation of protein nitration by liquid chromatography-mass spectrometry using isotope-coded dimethyl labeling and chemoprecipitation.

Authors:  Jia Guo; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  J Chromatogr A       Date:  2012-01-09       Impact factor: 4.759

2.  C-phycocyanin prevents cisplatin-induced mitochondrial dysfunction and oxidative stress.

Authors:  Berenice Fernández-Rojas; Daniela Sarai Rodríguez-Rangel; Luis Fernando Granados-Castro; Mario Negrette-Guzmán; Juan Carlos León-Contreras; Rogelio Hernández-Pando; Eduardo Molina-Jijón; José L Reyes; Cecilia Zazueta; José Pedraza-Chaverri
Journal:  Mol Cell Biochem       Date:  2015-05-14       Impact factor: 3.396

3.  Fluorogenic Tagging of Peptide and Protein 3-Nitrotyrosine with 4-(Aminomethyl)-benzenesulfonic Acid for Quantitative Analysis of Protein Tyrosine Nitration.

Authors:  Victor S Sharov; Elena S Dremina; Nadezhda A Galeva; Gary S Gerstenecker; Xiaobao Li; Rick T Dobrowsky; John F Stobaugh; Christian Schöneich
Journal:  Chromatographia       Date:  2010-01-01       Impact factor: 2.044

Review 4.  Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches.

Authors:  Ana Cipak Gasparovic; Neven Zarkovic; Kamelija Zarkovic; Khrystyna Semen; Danylo Kaminskyy; Olha Yelisyeyeva; Serge P Bottari
Journal:  Br J Pharmacol       Date:  2017-03-06       Impact factor: 8.739

5.  Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications.

Authors:  Xiaoguang Sunny Li; Shu Li; Melissa Ahrens; Gottfried Kellermann
Journal:  J Vis Exp       Date:  2017-07-14       Impact factor: 1.355

6.  Direct detection of nitrotyrosine-containing proteins using an aniline-based oxidative coupling strategy.

Authors:  Rapeepat Sangsuwan; Allie C Obermeyer; Phum Tachachartvanich; Krishnan K Palaniappan; Matthew B Francis
Journal:  Chem Commun (Camb)       Date:  2016-07-22       Impact factor: 6.222

7.  Nitro-fatty acids occur in human plasma in the picomolar range: a targeted nitro-lipidomics GC-MS/MS study.

Authors:  Dimitrios Tsikas; Alexander A Zoerner; Anja Mitschke; Frank-Mathias Gutzki
Journal:  Lipids       Date:  2009-08-22       Impact factor: 1.880

8.  The biology of ergothioneine, an antioxidant nutraceutical.

Authors:  Irina Borodina; Louise C Kenny; Cathal M McCarthy; Kalaivani Paramasivan; Etheresia Pretorius; Timothy J Roberts; Steven A van der Hoek; Douglas B Kell
Journal:  Nutr Res Rev       Date:  2020-02-13       Impact factor: 7.800

Review 9.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.